Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gila Lithwick-Yanai

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Biochemical and Biophysical Research Communications|September 4, 2008
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cellsHilah Gal, Gopal Pandi, Andrew A Kanner, et al.
Leukemia Research|April 14, 2015
MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphomaDaniel Shepshelovich, Ron Ram, Orit Uziel, et al.
Gynecologic Oncology|May 19, 2009
Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patientsRam Eitan, Michal Kushnir, Gila Lithwick-Yanai, et al.
Nature Cell Biology|February 26, 2025
Systematic reconstruction of molecular pathway signatures using scalable single-cell perturbation screensLongda Jiang, Carol Dalgarno, Efthymia Papalexi, et al.
International Journal of Oncology|March 20, 2012
Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancerAlina Weissmann-Brenner, Michal Kushnir, Gila Lithwick Yanai, et al.
Nucleic Acids Research|May 21, 2010
Discovery of microRNAs and other small RNAs in solid tumorsEti Meiri, Asaf Levy, Hila Benjamin, et al.
Pathology, Research and Practice|April 27, 2010
MicroRNA expression differentiates between primary lung tumors and metastases to the lungIris Barshack, Gila Lithwick-Yanai, Arnon Afek, et al.
Journal of Cellular and Molecular Medicine|May 14, 2020
Differential expression of microRNA in serum fractions and association of Argonaute 1 microRNAs with heart failureEti Meiri, Natalia Volinsky, Nir Dromi, et al.
Nature Biotechnology|September 15, 2022
Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencingSean K Simmons, Gila Lithwick-Yanai, Xian Adiconis, et al.
Brain Pathology (Zurich, Switzerland)|July 16, 2008
MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumorsDvora Nass, Shai Rosenwald, Eti Meiri, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|September 4, 2008
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cellsHilah Gal, Gopal Pandi, Andrew A Kanner, et al.
Leukemia Research|April 14, 2015
MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphomaDaniel Shepshelovich, Ron Ram, Orit Uziel, et al.
Gynecologic Oncology|May 19, 2009
Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patientsRam Eitan, Michal Kushnir, Gila Lithwick-Yanai, et al.
Nature Cell Biology|February 26, 2025
Systematic reconstruction of molecular pathway signatures using scalable single-cell perturbation screensLongda Jiang, Carol Dalgarno, Efthymia Papalexi, et al.
International Journal of Oncology|March 20, 2012
Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancerAlina Weissmann-Brenner, Michal Kushnir, Gila Lithwick Yanai, et al.
Nucleic Acids Research|May 21, 2010
Discovery of microRNAs and other small RNAs in solid tumorsEti Meiri, Asaf Levy, Hila Benjamin, et al.
Pathology, Research and Practice|April 27, 2010
MicroRNA expression differentiates between primary lung tumors and metastases to the lungIris Barshack, Gila Lithwick-Yanai, Arnon Afek, et al.
Journal of Cellular and Molecular Medicine|May 14, 2020
Differential expression of microRNA in serum fractions and association of Argonaute 1 microRNAs with heart failureEti Meiri, Natalia Volinsky, Nir Dromi, et al.
Nature Biotechnology|September 15, 2022
Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencingSean K Simmons, Gila Lithwick-Yanai, Xian Adiconis, et al.
Brain Pathology (Zurich, Switzerland)|July 16, 2008
MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumorsDvora Nass, Shai Rosenwald, Eti Meiri, et al.
Pageof 2